Article Sidebar

PDF
Published: 2021-12-31
Abstract Views: 322
Views PDF: 220
DOI: https://doi.org/10.52852/tcncyh.v148i12.772
Issue
Vol. 148 No. 12 (2021): Tập 148 số 12 E9
Section
Các bài báo
How to Cite
Tung, T. T., Quang, T. V. ., Phuong , P. V. N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., Hoang, D. V. ., & Hien, D. T. T. (2021). Evaluation effects of “An Tri Khang” hard capsule on scopolamine-induced memory impairment in experimental animals. Journal of Medical Research, 148(12), 1-6. https://doi.org/10.52852/tcncyh.v148i12.772

Evaluation effects of “An Tri Khang” hard capsule on scopolamine-induced memory impairment in experimental animals

Tran Thanh Tung, Trinh Vinh Quang, Phan Van Nam Phuong , Dao Viet Hoang, Dang Thi Thu Hien

Main Article Content

Abstract

This study was performed to investigate the effects of An Tri Khang (ATK) hard capsule on scopolamine-induced memory impairment in experimental animals. The effects on memory of oral administration ATK were evaluated on scopolamine-induced memory impairment in experimental animals. The memory improvement effects were conducted on 2 experimental models: the Morris water maze (MWM) and the Multi-T maze (MTM). In the MWM model, ATK significantly reduced the time spent and pathlength to platform, increased the percentage of time swimming in platform’s quadrant. Swiss mice performed the MTM with shorter in both the time spent and the pathlength to the goal box (p < 0.01). Both doses of ATK attenuated scopolamine-mediated impairment of memory. ATK has potential effects on memory improvement. It is suggested that further clinical trials should be undertaken to have thorough assessment on human.

Article Details

Keywords

An Tri Khang, Morris water maze, Multi T maze, scopolamine, experimental animals

References

1. World Health Organization. Dementia: Fact sheets. World Health Organization. Published online 2020.
2. Kumar A, Sidhu J, Goyal A, Tsao JW. Alzheimer Disease. In: StatPearls. StatPearls Publishing; 2020.
3. Jakob-Roetne R, Jacobsen H. Alzheimer’s disease: from pathology to therapeutic approaches. Angew Chem Int Ed Engl. 2009;48(17):3030-3059.
4. Casey DA, Antimisiaris D, O’Brien J. Drugs for Alzheimer’s Disease: Are They Effective?. P T. 2010;35(4):208-211.
5. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16(3):666-674.
6. Tan M-S, Yu J-T, Tan C-C, et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2015;43(2):589-603.
7. Chen H-W, He X-H, Yuan R, et al. Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia. 2016;110:142-149.
8. Wang P, Ran X-H, Luo H-R, et al. Phenolic Compounds from the Roots of Valeriana officinalis var. latifolia. Journal of the Brazilian Chemical Society. 2013;24:1544-1548.
9. Falsafi SK, Deli A, Höger H, Pollak A, Lubec G. Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems. PLoS ONE. 2012;7(2):e32082.
10. B L, I S, H L, Dh H. Rehmannia glutinosa ameliorates scopolamine-induced learning and memory impairment in rats. Journal of microbiology and biotechnology.
11. Wang J, Wang X, Lv B, et al. Effects of Fructus Akebiae on learning and memory impairment in a scopolamine-induced
animal model of dementia. Exp Ther Med. 2014;8(2):671-675.
12. Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev.
2002;(4):CD003120.
13. Kumar A, Sharma S. Donepezil. In: StatPearls. StatPearls Publishing; 2020.
14. N G, O M, T U, I KC, Ss G, G U. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacology, biochemistry, and behavior.
15. Park I-K. Fumigant toxicity of Oriental sweetgum (Liquidambar orientalis) and valerian (Valeriana wallichii) essential oils and their components, including their acetylcholinesterase inhibitory activity, against Japanese termites (Reticulitermes speratus). Molecules. 2014;19(8):12547-12558.
16. Nathan P. Can the cognitive enhancing effects of ginkgo biloba be explained by its pharmacology? Med Hypotheses. 2000;55(6):491-493.
17. Li S, Cheng X, Wang C. A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J Ethnopharmacol. 2017;203:127-162.
18. Ninh The S, Kamiji M, Huong T, Kubo M, Cuong N, Fukuyama Y. Chemical constituents of the Vietnamese plants Dalbergia tonkinensis Prain and Cratoxylum formosum (Jack) Dyer in Hook and their DPPH radical scavenging activities. Medicinal Chemistry Research. 2019;28.
19. D’Orlando KJ, Sandage BW. Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. Neurol Res. 1995;17(4):281-284.